These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks. Wagner JP; Wolf-Yadlin A; Sevecka M; Grenier JK; Root DE; Lauffenburger DA; MacBeath G Sci Signal; 2013 Jul; 6(284):ra58. PubMed ID: 23861540 [TBL] [Abstract][Full Text] [Related]
44. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors. Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858 [TBL] [Abstract][Full Text] [Related]
45. The single transmembrane domains of human receptor tyrosine kinases encode self-interactions. Finger C; Escher C; Schneider D Sci Signal; 2009 Sep; 2(89):ra56. PubMed ID: 19797273 [TBL] [Abstract][Full Text] [Related]
46. Nuclear receptor tyrosine kinase transport and functions in cancer. Chen MK; Hsu JL; Hung MC Adv Cancer Res; 2020; 147():59-107. PubMed ID: 32593407 [TBL] [Abstract][Full Text] [Related]
47. Cell-Surface Expression Levels Are Important for Fine-Tuning the Performance of Receptor Tyrosine Kinase-Based Signalobodies. Nakabayashi H; Kawahara M; Nagamune T Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28881109 [TBL] [Abstract][Full Text] [Related]
48. Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling. Liebmann C; Böhmer FD Curr Med Chem; 2000 Sep; 7(9):911-43. PubMed ID: 10911023 [TBL] [Abstract][Full Text] [Related]
49. Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases. Endres NF; Barros T; Cantor AJ; Kuriyan J Trends Biochem Sci; 2014 Oct; 39(10):437-46. PubMed ID: 25242369 [TBL] [Abstract][Full Text] [Related]
51. Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time. Fantauzzo KA; Soriano P Curr Top Dev Biol; 2015; 111():135-82. PubMed ID: 25662260 [TBL] [Abstract][Full Text] [Related]
52. Tyrosine kinase receptors as attractive targets of cancer therapy. Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157 [TBL] [Abstract][Full Text] [Related]
53. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium. Fuller SJ; Sivarajah K; Sugden PH J Mol Cell Cardiol; 2008 May; 44(5):831-54. PubMed ID: 18430438 [TBL] [Abstract][Full Text] [Related]
54. Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation. Raffioni S; Zhu YZ; Bradshaw RA; Thompson LM J Biol Chem; 1998 Dec; 273(52):35250-9. PubMed ID: 9857065 [TBL] [Abstract][Full Text] [Related]
55. Regulation of receptor tyrosine kinase ligand processing. Adrain C; Freeman M Cold Spring Harb Perspect Biol; 2014 Jan; 6(1):. PubMed ID: 24384567 [TBL] [Abstract][Full Text] [Related]
56. Arabidopsis Transmembrane Receptor-Like Kinases (RLKs): A Bridge between Extracellular Signal and Intracellular Regulatory Machinery. Jose J; Ghantasala S; Roy Choudhury S Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503273 [TBL] [Abstract][Full Text] [Related]